These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 36726200)
1. USP53 Regulates Bone Homeostasis by Controlling Rankl Expression in Osteoblasts and Bone Marrow Adipocytes. Hariri H; Kose O; Bezdjian A; Daniel SJ; St-Arnaud R J Bone Miner Res; 2023 Apr; 38(4):578-596. PubMed ID: 36726200 [TBL] [Abstract][Full Text] [Related]
2. Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow. Mousa A; Cui C; Song A; Myneni VD; Sun H; Li JJ; Murshed M; Melino G; Kaartinen MT Cell Death Differ; 2017 May; 24(5):844-854. PubMed ID: 28387755 [TBL] [Abstract][Full Text] [Related]
3. Cortactin controls bone homeostasis through regulating the differentiation of osteoblasts and osteoclasts. Yang X; Chen M; Wang S; Hu X; Zhou J; Yuan H; Zhu E; Wang B Stem Cells; 2024 Jul; 42(7):662-674. PubMed ID: 38655781 [TBL] [Abstract][Full Text] [Related]
4. Ubiquitin specific peptidase Usp53 regulates osteoblast versus adipocyte lineage commitment. Hariri H; Addison WN; St-Arnaud R Sci Rep; 2021 Apr; 11(1):8418. PubMed ID: 33875709 [TBL] [Abstract][Full Text] [Related]
5. IL-1 plays an important role in the bone metabolism under physiological conditions. Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512 [TBL] [Abstract][Full Text] [Related]
6. Overloaded Orthopedic Force Induces Condylar Subchondral Bone Absorption by Stimulating Rat Mesenchymal Stem Cells Differentiating into Osteoclasts via mTOR-Regulated Tian Y; Chen J; Yan X; Ren D; Liu M; Zhang Q; Zhang Q; Yuan X Stem Cells Dev; 2021 Jan; 30(1):29-38. PubMed ID: 33176606 [TBL] [Abstract][Full Text] [Related]
7. Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone. Cappariello A; Loftus A; Muraca M; Maurizi A; Rucci N; Teti A J Bone Miner Res; 2018 Mar; 33(3):517-533. PubMed ID: 29091316 [TBL] [Abstract][Full Text] [Related]
8. Galectin-3 as a novel regulator of osteoblast-osteoclast interaction and bone homeostasis. Simon D; Derer A; Andes FT; Lezuo P; Bozec A; Schett G; Herrmann M; Harre U Bone; 2017 Dec; 105():35-41. PubMed ID: 28822790 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-29a represses osteoclast formation and protects against osteoporosis by regulating PCAF-mediated RANKL and CXCL12. Lian WS; Ko JY; Chen YS; Ke HJ; Hsieh CK; Kuo CW; Wang SY; Huang BW; Tseng JG; Wang FS Cell Death Dis; 2019 Sep; 10(10):705. PubMed ID: 31543513 [TBL] [Abstract][Full Text] [Related]
10. Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development. Mukherjee A; Rotwein P Mol Cell Biol; 2012 Jan; 32(2):490-500. PubMed ID: 22064480 [TBL] [Abstract][Full Text] [Related]
11. IL-3 Differentially Regulates Membrane and Soluble RANKL in Osteoblasts through Metalloproteases and the JAK2/STAT5 Pathway and Improves the RANKL/OPG Ratio in Adult Mice. Singh K; Piprode V; Mhaske ST; Barhanpurkar-Naik A; Wani MR J Immunol; 2018 Jan; 200(2):595-606. PubMed ID: 29203513 [TBL] [Abstract][Full Text] [Related]
12. Deficiency of osteoblastic Arl6ip5 impaired osteoblast differentiation and enhanced osteoclastogenesis via disturbance of ER calcium homeostasis and induction of ER stress-mediated apoptosis. Wu Y; Yang M; Fan J; Peng Y; Deng L; Ding Y; Yang R; Zhou J; Miao D; Fu Q Cell Death Dis; 2014 Oct; 5(10):e1464. PubMed ID: 25321471 [TBL] [Abstract][Full Text] [Related]
13. SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts. Xu Z; Greenblatt MB; Yan G; Feng H; Sun J; Lotinun S; Brady N; Baron R; Glimcher LH; Zou W Nat Commun; 2017 Feb; 8():14570. PubMed ID: 28216630 [TBL] [Abstract][Full Text] [Related]
14. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation. Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486 [TBL] [Abstract][Full Text] [Related]
15. Mst2 Controls Bone Homeostasis by Regulating Osteoclast and Osteoblast Differentiation. Lee J; Youn BU; Kim K; Kim JH; Lee DH; Seong S; Kim I; Han SH; Che X; Choi JY; Park YW; Kook H; Kim KK; Lim DS; Kim N J Bone Miner Res; 2015 Sep; 30(9):1597-607. PubMed ID: 25761670 [TBL] [Abstract][Full Text] [Related]
16. IDH2 deficiency increases bone mass with reduced osteoclastogenesis by limiting RANKL expression in osteoblasts. Lee SH; Lee SH; Lee JH; Park JW; Kim JE Bone; 2019 Dec; 129():115056. PubMed ID: 31479775 [TBL] [Abstract][Full Text] [Related]
17. Histone demethylase KDM7A regulates bone homeostasis through balancing osteoblast and osteoclast differentiation. Shan L; Yang X; Liao X; Yang Z; Zhou J; Li X; Wang B Cell Death Dis; 2024 Feb; 15(2):136. PubMed ID: 38346941 [TBL] [Abstract][Full Text] [Related]
18. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo. Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094 [TBL] [Abstract][Full Text] [Related]
19. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1. Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]